MedTrace Logo

The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer

NCT01444755 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2011-10-03

No results posted yet for this study

Summary

The aim of this study is to evaluate survival benefit of a neoadjuvant chemotherapy regimen in patient with resectable locally advanced gastric cancer in comparison with surgery alone.

Conditions

Sponsors & Collaborators

  • Haydarpasa Numune Training and Research Hospital

    lead OTHER

Principal Investigators

  • Atilla Celik, M.D. · Haydarpasa Numune Teaching & Research Hospital, Affiliated by Ministery of Health of Turkey

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2012-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444755 on ClinicalTrials.gov